ABOS Announces 2024-2025 Board of Directors

The Board of Directors of the American Board of Orthopaedic Surgery (ABOS) recently announced its 2024-2025 officers as well as two new directors-elect. The mission of the ABOS is to ensure safe, ethical, and effective practice of orthopedic surgery. ABOS maintains the highest standards for education, practice, and conduct through examination, certification, and maintenance of certification for the benefit of the public.

Kevin L. Garvin, M.D., the L. Thomas Hood, M.D. Professor and Chair, Department of Orthopaedic Surgery and Rehabilitation, University of Nebraska, is the new ABOS president. Dr. Garvin, along with the president-elect, vice president, and secretary, hold their offices for a one-year term.

“The ABOS has a strong history and tradition dating back to 1934,” said Dr. Garvin to OTW. “My first goal as president is to just maintain the high value of things that we do in assessing orthopaedic surgeons’ competence. And the motto that we have, which is really our foundation, is protecting the public. In doing so, really what we’re doing is putting the patients first.”

Additional ABOS Officers elected were:

Wayne J. Sebastianelli, M.D., the Kalenak Professor in Orthopaedics at Penn State Health Milton S. Hershey Medical Center and Medical Director, Penn State Sports Medicine, will serve as ABOS vice president.

Charles L. Nelson, M.D., Chief of Adult Reconstruction Surgery at the University of Pennsylvania Health System and Professor of Orthopaedic Surgery at the Hospital of the University of Pennsylvania, will serve as ABOS president-elect.

Lisa A. Taitsman, M.D., M.P.H., Professor of Orthopaedics and Sports Medicine, University of Washington School of Medicine, will serve as ABOS secretary.

Kyle J. Jeray, M.D., Chair of the Department of Orthopaedic Surgery at Prisma Health-Update, has been re-elected as ABOS treasurer for a one-year term.

“Once again, the Board has elected an outstanding group of Officers,” said David F. Martin, M.D., ABOS executive director. “They are all leaders in the field and the Board is lucky to have them serve as they are all busy surgeons.”

The Board elected Dawn M. LaPorte, M.D., Professor of Orthopaedic Surgery at Johns Hopkins Hospital and School of Medicine, and Jennifer Moriatis Wolf, M.D., Ph.D., Professor and Chair of the Department of Orthopaedic Surgery at The University of Chicago, as new director-elects of the American Board of Orthopaedic Surgery.

“The American Medical Association and the American Academy of Orthopaedic Surgeons both supplied outstanding slates of nominees from which the Board could select,” said Dr. Martin. “Dr. LaPorte and Dr. Wolf bring a tremendous amount of energy and significant skills to the organization.”

The ABOS Board of Directors consists of 21 members, which includes 12 active directors, six senior directors, two directors-elect, and one public member director. ABOS Board Members serve one 10-year term while the public member director serves a three-year renewable term. Nominations to the ABOS Board of Directors come from the American Orthopaedic Association, the American Academy of Orthopaedic Surgeons, and the American Medical Association. Officers are current Board members elected by other Board members.